Lead the world! BRL Medicine's new generation of Quikin CAR-T research results published in Nature
2022-09-01
BRL Medicine's β-Thalassemia Gene Therapy " BRL-101 " obtained IND approval from CDE
2022-08-16
Nature Medicine article states that BRL-101 gene therapy for thalassemia has cured children for over 2 years
2022-08-04
2022 Future Healthcare VB100｜BRL Medicine awarded as
2022-06-16
BRL Medicine Inc. formally appointed Dr. Biao Zheng as CEO
2022-05-20
Change of Entity English Name Letter of Notification
2022-01-07
